麝香保心丸辅助常规西药治疗急性心肌梗死气滞血瘀证临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R542.2+2

基金项目:


Clinical Study on Shexiang Baoxin Pills Assisting Routine Western Medicine for Acute Myocardial Infarction with Qi Stagnation and Blood Stasis Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察麝香保心丸辅助常规西药治疗急性心肌梗死(AMI) 气滞血瘀证的临床疗效。方法:选取AMI 患者95 例,按随机数字表法分为麝香保心丸组50 例与常规组45 例。常规组给予常规西药治疗,麝香保心丸组在常规组治疗方案的基础上加用麝香保心丸治疗。治疗8 周后,比较2 组临床疗效、症状改善情况,并检测心功能[左心室射血分数(LVEF)、左心室收缩末期容积(LVESV)、左心室舒张末期容积(LVEDV)]、血管内皮功能[一氧化氮(NO)、内皮素(ET)]。结果:临床总有效率麝香保心丸组96.00%,高于常规组75.56%,差异有统计学意义(P<0.05)。治疗后,2 组中医证候积分较治疗前下降(P<0.05),且麝香保心丸组低于常规组(P<0.05)。治疗后,2 组LVEF 水平较治疗前上升,LVESV、LVEDV 水平较治疗前下降(P<0.05),麝香保心丸组LVEF 水平高于常规组,LVESV、LVEDV 水平低于常规组(P<0.05)。治疗后,2 组血清NO 水平较治疗前上升,血清ET 水平较治疗前下降(P<0.05),麝香保心丸组血清NO 水平高于常规组,血清ET 水平低于常规组(P<0.05)。结论:麝香保心丸辅助常规西药治疗AMI 气滞血瘀证疗效确切,可有效帮助患者减轻临床症状,使其心功能、血管内皮功能明显改善。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Shexiang Baoxin pills assisting routine western medicine for acute myocardial infarction(AMI) with qi stagnation and blood stasis syndrome. Methods:A total of 95 cases of AMI patients were selected and divided into the Shexiang Baoxin pills group and the routine group according to the random number table method,50 and 45 cases in each group respectively. The routine group was treated with routine western medicine,and the Shexiang Baoxin pills group was additionally treated with Shexiang Baoxin pills based on the treatment of the routine group. After eight-week treatment,the clinical effect and the improvement of symptoms in the two groups were compared;the heart function including left ventricular ejection fraction(LVEF),left ventricular end-systolic volume(LVESV) and left ventricular end-diastolic volume(LVEDV) as well as the vascular endothelial function including nitric oxide(NO) and endothelin(ET) in the two groups were detected. Results:The total clinical effective rate was 96.00% in the Shexiang Baoxin pills group,higher than that of 75.56% in the routine group, the difference being significant(P<0.05). After treatment, Chinese medicine syndrome scores in the two groups were decreased when compared with those before treatment(P<0.05),and the score in the Shexiang Baoxin pills group was lower than that in the routine group(P<0.05). After treatment,LVEF levels in the two groups were increased when compared with those before treatment,and levels of LVESV and LVEDV were decreased(P< 0.05); LVEF level in the Shexiang Baoxin pills group was higher than that in the routine group, and levels of LVESV and LVEDV were lower(P<0.05). After treatment, NO levels in serum in the two groups were increased when compared with those before treatment,and ET levels in serum were decreased(P<0.05);NO level in the Shexiang Baoxin pills group was higher than that in the routine group,and ET level was lower(P<0.05). Conclusion:Shexiang Baoxin pills assisting routine western medicine for AMI with qi stagnation and blood stasis syndrome has definite curative effect, which can effectively help patients to relieve clinical symptoms and significantly improve their heart function and vascular endothelial function.

    参考文献
    相似文献
    引证文献
引用本文

潘欢军.麝香保心丸辅助常规西药治疗急性心肌梗死气滞血瘀证临床研究[J].新中医,2021,53(6):34-37

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-03-25
  • 出版日期: